Drug intelligence / Profile preview

Jieyu prescription

Development stage
Preclinical
Lead developer
Wenzhou Hospital of Traditional Chinese Medicine
Administration
Oral
01

Overview

Jieyu prescription refers to a category of traditional Chinese medicine (TCM) formulations designed to alleviate depression. The specific "self-designed Jieyu prescription" mentioned in the clinical trial context is being investigated by Wenzhou Hospital of Traditional Chinese Medicine for the treatment of post-stroke depression (PSD). Administered orally, its therapeutic effects are believed to involve the modulation of the gut microbiota, influencing the gut-brain axis, and potentially inhibiting neuroinflammation and regulating the hypothalamic-pituitary-adrenal (HPA) axis. Other proposed mechanisms for various Jieyu formulations include increasing levels of neurotransmitters like serotonin and GABA, and neurotrophic factors such as BDNF.

Other names
self-designed Jieyu prescription
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)ESR1 (ERα)IL-6 (Interleukin 6)MYD88 (Myeloid differentiation primary response protein MyD88)TLR4 (Toll-like receptor 4)VEGFA (Vascular endothelial growth factor A)

Beyond the preview

Go deeper on Jieyu prescription.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jieyu prescription.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call